Silvercrest Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,585
| Closed | -$79.5K | – | 825 |
|
|
2022
Q4 | $79.5K | Hold |
12,585
| – | – | ﹤0.01% | 770 |
|
|
2022
Q3 | $64K | Hold |
12,585
| – | – | ﹤0.01% | 775 |
|
|
2022
Q2 | $79K | Hold |
12,585
| – | – | ﹤0.01% | 779 |
|
|
2022
Q1 | $45K | Hold |
12,585
| – | – | ﹤0.01% | 836 |
|
|
2021
Q4 | $63K | Sell |
12,585
-250
| -2% | -$1.25K | ﹤0.01% | 815 |
|
|
2021
Q3 | $94K | Hold |
12,835
| – | – | ﹤0.01% | 832 |
|
|
2021
Q2 | $110K | Hold |
12,835
| – | – | ﹤0.01% | 818 |
|
|
2021
Q1 | $139K | Hold |
12,835
| – | – | ﹤0.01% | 819 |
|
|
2020
Q4 | $127K | Sell |
12,835
-1
| -0% | -$10 | ﹤0.01% | 778 |
|
|
2020
Q3 | $69K | Hold |
12,836
| – | – | ﹤0.01% | 739 |
|
|
2020
Q2 | $75K | Hold |
12,836
| – | – | ﹤0.01% | 723 |
|
|
2020
Q1 | $48K | Hold |
12,836
| – | – | ﹤0.01% | 693 |
|
|
2019
Q4 | $81K | Sell |
12,836
-3,000
| -19% | -$18.9K | ﹤0.01% | 739 |
|
|
2019
Q3 | $218K | Hold |
15,836
| – | – | ﹤0.01% | 681 |
|
|
2019
Q2 | $234K | Hold |
15,836
| – | – | ﹤0.01% | 519 |
|
|
2019
Q1 | $664K | Hold |
15,836
| – | – | 0.01% | 408 |
|
|
2018
Q4 | $658K | Hold |
15,836
| – | – | 0.01% | 376 |
|
|
2018
Q3 | $763K | Hold |
15,836
| – | – | 0.01% | 383 |
|
|
2018
Q2 | $751K | Hold |
15,836
| – | – | 0.01% | 381 |
|
|
2018
Q1 | $974K | Hold |
15,836
| – | – | 0.01% | 360 |
|
|
2017
Q4 | $851K | Sell |
15,836
-2,500
| -14% | -$134K | 0.01% | 374 |
|
|
2017
Q3 | $1.24M | Hold |
18,336
| – | – | 0.01% | 347 |
|
|
2017
Q2 | $993K | Buy |
+18,336
| New | +$993K | 0.01% | 351 |
|
|
2017
Q1 | – | Sell |
-24,322
| Closed | -$777K | – | 589 |
|
|
2016
Q4 | $777K | Buy |
+24,322
| New | +$777K | 0.01% | 370 |
|